Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa04926 | Relaxin signaling pathway | 118/6408 | 129/8135 | 0.0000833 | 0.0003864 | 0.0001486 | 118 | RABC39 | |
| KEGG | hsa05140 | Leishmaniasis | 73/6408 | 77/8135 | 0.0000872 | 0.0003988 | 0.0001533 | 73 | RABC39 | |
| KEGG | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 93/6408 | 100/8135 | 0.00009 | 0.0004061 | 0.0001561 | 93 | RABC39 | |
| KEGG | hsa04919 | Thyroid hormone signaling pathway | 111/6408 | 121/8135 | 0.0000983 | 0.0004378 | 0.0001683 | 111 | RABC39 | |
| KEGG | hsa04370 | VEGF signaling pathway | 57/6408 | 59/8135 | 0.0001042 | 0.0004573 | 0.0001758 | 57 | RABC39 | |
| KEGG | hsa05212 | Pancreatic cancer | 72/6408 | 76/8135 | 0.0001054 | 0.0004573 | 0.0001758 | 72 | RABC39 | |
| KEGG | hsa04146 | Peroxisome | 77/6408 | 82/8135 | 0.00015 | 0.0006276 | 0.0002413 | 77 | RABC39 | |
| KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 90/6408 | 97/8135 | 0.0001503 | 0.0006276 | 0.0002413 | 90 | RABC39 | |
| KEGG | hsa04713 | Circadian entrainment | 90/6408 | 97/8135 | 0.0001503 | 0.0006276 | 0.0002413 | 90 | RABC39 | |
| KEGG | hsa05134 | Legionellosis | 55/6408 | 57/8135 | 0.0001578 | 0.0006506 | 0.0002502 | 55 | RABC39 | |
| KEGG | hsa04915 | Estrogen signaling pathway | 125/6408 | 138/8135 | 0.0001661 | 0.0006636 | 0.0002551 | 125 | RABC39 | |
| KEGG | hsa04211 | Longevity regulating pathway | 83/6408 | 89/8135 | 0.0001669 | 0.0006636 | 0.0002551 | 83 | RABC39 | |
| KEGG | hsa04727 | GABAergic synapse | 83/6408 | 89/8135 | 0.0001669 | 0.0006636 | 0.0002551 | 83 | RABC39 | |
| KEGG | hsa04611 | Platelet activation | 113/6408 | 124/8135 | 0.0001804 | 0.0007088 | 0.0002725 | 113 | RABC39 | |
| KEGG | hsa04510 | Focal adhesion | 178/6408 | 201/8135 | 0.0001848 | 0.0007176 | 0.0002759 | 178 | RABC39 | |
| KEGG | hsa05218 | Melanoma | 68/6408 | 72/8135 | 0.0002241 | 0.0008602 | 0.0003307 | 68 | RABC39 | |
| KEGG | hsa04657 | IL-17 signaling pathway | 87/6408 | 94/8135 | 0.0002495 | 0.0009471 | 0.0003642 | 87 | RABC39 | |
| KEGG | hsa04931 | Insulin resistance | 99/6408 | 108/8135 | 0.0002562 | 0.0009613 | 0.0003696 | 99 | RABC39 | |
| KEGG | hsa04022 | cGMP-PKG signaling pathway | 149/6408 | 167/8135 | 0.0002653 | 0.0009844 | 0.0003785 | 149 | RABC39 | |
| KEGG | hsa04922 | Glucagon signaling pathway | 98/6408 | 107/8135 | 0.0003 | 0.001101 | 0.0004234 | 98 | RABC39 | |
| KEGG | hsa04917 | Prolactin signaling pathway | 66/6408 | 70/8135 | 0.0003252 | 0.001181 | 0.000454 | 66 | RABC39 | |
| KEGG | hsa04610 | Complement and coagulation cascades | 79/6408 | 85/8135 | 0.000334 | 0.001199 | 0.0004612 | 79 | RABC39 | |
| KEGG | hsa04725 | Cholinergic synapse | 103/6408 | 113/8135 | 0.0003429 | 0.001219 | 0.0004685 | 103 | RABC39 | |
| KEGG | hsa04130 | SNARE interactions in vesicular transport | 33/6408 | 33/8135 | 0.0003736 | 0.001314 | 0.0005051 | 33 | RABC39 | |
| KEGG | hsa04071 | Sphingolipid signaling pathway | 108/6408 | 119/8135 | 0.0003836 | 0.001335 | 0.0005132 | 108 | RABC39 | |
| KEGG | hsa04750 | Inflammatory mediator regulation of TRP channels | 90/6408 | 98/8135 | 0.0004153 | 0.001416 | 0.0005443 | 90 | RABC39 | |
| KEGG | hsa04925 | Aldosterone synthesis and secretion | 90/6408 | 98/8135 | 0.0004153 | 0.001416 | 0.0005443 | 90 | RABC39 | |
| KEGG | hsa04940 | Type I diabetes mellitus | 42/6408 | 43/8135 | 0.0004298 | 0.00145 | 0.0005575 | 42 | RABC39 | |
| KEGG | hsa04650 | Natural killer cell mediated cytotoxicity | 118/6408 | 131/8135 | 0.0004564 | 0.001524 | 0.0005861 | 118 | RABC39 | |
| KEGG | hsa05221 | Acute myeloid leukemia | 63/6408 | 67/8135 | 0.0005654 | 0.00187 | 0.0007189 | 63 | RABC39 |